Le Qin
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Oncology 24
- CAR-T cell therapy research 16
-
- Genomics and Phylogenetic Studies 5
- Co-authors
- Fuhua Yan (21 shared papers)Wenjie Yang (23 shared papers)Qiqi Cao (6 shared papers)Zenghui Cheng (6 shared papers)Ashan Pan (3 shared papers)Qingfeng Sun (3 shared papers)Jianyi Dai (3 shared papers)Peng Li (15 shared papers)
- Journals
- European Radiology (6 papers)American Journal of Roentgenology (3 papers)BMC Cancer (3 papers)Scientific Reports (3 papers)International Journal of Cardiology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Le Qin
99 papers receiving 2.4k citations
Le Qin's Hit Papers
Peers
Comparison fields: 5 of 146
- Infectious Diseases 650
- Oncology 630
- Radiology, Nuclear Medicine and Imaging 375
- Critical Care and Intensive Care Medicine 66
- Neurology 201
Countries citing papers authored by Le Qin
This map shows the geographic impact of Le Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Qin more than expected).
Fields of papers citing papers by Le Qin
This network shows the impact of papers produced by Le Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Qin. The network helps show where Le Qin may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China Hit paper breakdown → | 2020 | 683 |
| 2 | 2017 | 225 | |
| 3 | 2020 | 219 | |
| 4 | 2017 | 110 | |
| 5 | 2017 | 80 | |
| 6 | 2017 | 79 | |
| 7 | 2020 | 52 | |
| 8 | 2022 | 48 | |
| 9 | 2009 | 46 | |
| 10 | 2021 | 39 | |
| 11 | 2020 | 35 | |
| 12 | 2021 | 31 | |
| 13 | 2016 | 31 | |
| 14 | 2020 | 31 | |
| 15 | 2023 | 31 | |
| 16 | 2020 | 31 | |
| 17 | 2020 | 30 | |
| 18 | 2019 | 29 | |
| 19 | 2020 | 27 | |
| 20 | 2024 | 26 |
About Le Qin
Le Qin is a scholar working on Oncology, Molecular Biology, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 106 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Advanced X-ray and CT Imaging (9 papers), Microbial Natural Products and Biosynthesis (7 papers), Virus-based gene therapy research (6 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers), COVID-19 Clinical Research Studies (5 papers) and Genomics and Phylogenetic Studies (5 papers). The work is most often cited by research in Infectious Diseases (650 citations), Oncology (630 citations), Radiology, Nuclear Medicine and Imaging (375 citations), Critical Care and Intensive Care Medicine (66 citations) and Neurology (201 citations). Le Qin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fuhua Yan, Wenjie Yang, Qiqi Cao, Zenghui Cheng, Ashan Pan, Qingfeng Sun, Jianyi Dai, Peng Li, Jieming Qu and Xiaoyang Wang. Their work appears in journals such as European Radiology, American Journal of Roentgenology, BMC Cancer, Scientific Reports and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.